ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anticoagulant Drugs Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-32G5152
Home | Market Reports | Health| Pharmacy| Drugs & Medications
China Anticoagulant Drugs Market Report Forecast 2021 2027
BUY CHAPTERS

Global Anticoagulant Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-32G5152
Report
July 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Bayer
Johnson & Johnson
Daiichi Sankyo
Pfizer Inc
Sanofi
Boehringer Ingelheim

Anticoagulant Drugs Market Size

The global Anticoagulant Drugs market is projected to grow from US$ 30860 million in 2024 to US$ 40880 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Anticoagulant Drugs Market

Anticoagulant Drugs Market

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
Americas is the largest Anticoagulant Drugs market with about 51% market share. Europe is follower, accounting for about 27% market share.The key manufacturers are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo etc. Top 3 companies occupied about 56% market share.
Report Covers:
This report presents an overview of global market for Anticoagulant Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anticoagulant Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anticoagulant Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anticoagulant Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anticoagulant Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anticoagulant Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Anticoagulant Drugs Market Report

Report Metric Details
Report Name Anticoagulant Drugs Market
Accounted market size in 2024 US$ 30860 million
Forecasted market size in 2030 US$ 40880 million
CAGR 4.8
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • NOACs
  • Heparin
  • Warfarin
  • Others
Segment by Application
  • Hospital
  • Pharmacy
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Anticoagulant Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Anticoagulant Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anticoagulant Drugs sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Anticoagulant Drugs Market growing?

Ans: The Anticoagulant Drugs Market witnessing a CAGR of 4.8 during the forecast period 2024-2030.

What is the Anticoagulant Drugs Market size in 2030?

Ans: The Anticoagulant Drugs Market size in 2030 will be US$ 40880 million.

What is the Anticoagulant Drugs Market share by region?

Ans: Americas is the largest Anticoagulant Drugs market with about 51% market share. Europe is follower, accounting for about 27% market share.

What is the market share of major companies in Anticoagulant Drugs Market?

Ans: Top 3 companies occupied about 56% market share.

Who are the main players in the Anticoagulant Drugs Market report?

Ans: The main players in the Anticoagulant Drugs Market are Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo

What are the Application segmentation covered in the Anticoagulant Drugs Market report?

Ans: The Applications covered in the Anticoagulant Drugs Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Anticoagulant Drugs Market report?

Ans: The Types covered in the Anticoagulant Drugs Market report are NOACs, Heparin, Warfarin, Others

1 Study Coverage
1.1 Anticoagulant Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anticoagulant Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 NOACs
1.2.3 Heparin
1.2.4 Warfarin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anticoagulant Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anticoagulant Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Anticoagulant Drugs Revenue by Region
2.2.1 Global Anticoagulant Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Anticoagulant Drugs Revenue by Region (2019-2024)
2.2.3 Global Anticoagulant Drugs Revenue by Region (2025-2030)
2.2.4 Global Anticoagulant Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Anticoagulant Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Anticoagulant Drugs Sales by Region
2.4.1 Global Anticoagulant Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Anticoagulant Drugs Sales by Region (2019-2024)
2.4.3 Global Anticoagulant Drugs Sales by Region (2025-2030)
2.4.4 Global Anticoagulant Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anticoagulant Drugs Sales by Manufacturers
3.1.1 Global Anticoagulant Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Anticoagulant Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anticoagulant Drugs in 2023
3.2 Global Anticoagulant Drugs Revenue by Manufacturers
3.2.1 Global Anticoagulant Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Anticoagulant Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anticoagulant Drugs Revenue in 2023
3.3 Global Key Players of Anticoagulant Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Anticoagulant Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anticoagulant Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anticoagulant Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Anticoagulant Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anticoagulant Drugs Sales by Type
4.1.1 Global Anticoagulant Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Anticoagulant Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Anticoagulant Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anticoagulant Drugs Revenue by Type
4.2.1 Global Anticoagulant Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Anticoagulant Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Anticoagulant Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anticoagulant Drugs Price by Type
4.3.1 Global Anticoagulant Drugs Price by Type (2019-2024)
4.3.2 Global Anticoagulant Drugs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Anticoagulant Drugs Sales by Application
5.1.1 Global Anticoagulant Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Anticoagulant Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Anticoagulant Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anticoagulant Drugs Revenue by Application
5.2.1 Global Anticoagulant Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Anticoagulant Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Anticoagulant Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anticoagulant Drugs Price by Application
5.3.1 Global Anticoagulant Drugs Price by Application (2019-2024)
5.3.2 Global Anticoagulant Drugs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Anticoagulant Drugs Market Size by Type
6.1.1 US & Canada Anticoagulant Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Anticoagulant Drugs Revenue by Type (2019-2030)
6.2 US & Canada Anticoagulant Drugs Market Size by Application
6.2.1 US & Canada Anticoagulant Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Anticoagulant Drugs Revenue by Application (2019-2030)
6.3 US & Canada Anticoagulant Drugs Market Size by Country
6.3.1 US & Canada Anticoagulant Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Anticoagulant Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Anticoagulant Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anticoagulant Drugs Market Size by Type
7.1.1 Europe Anticoagulant Drugs Sales by Type (2019-2030)
7.1.2 Europe Anticoagulant Drugs Revenue by Type (2019-2030)
7.2 Europe Anticoagulant Drugs Market Size by Application
7.2.1 Europe Anticoagulant Drugs Sales by Application (2019-2030)
7.2.2 Europe Anticoagulant Drugs Revenue by Application (2019-2030)
7.3 Europe Anticoagulant Drugs Market Size by Country
7.3.1 Europe Anticoagulant Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Anticoagulant Drugs Sales by Country (2019-2030)
7.3.3 Europe Anticoagulant Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anticoagulant Drugs Market Size
8.1.1 China Anticoagulant Drugs Sales (2019-2030)
8.1.2 China Anticoagulant Drugs Revenue (2019-2030)
8.2 China Anticoagulant Drugs Market Size by Application
8.2.1 China Anticoagulant Drugs Sales by Application (2019-2030)
8.2.2 China Anticoagulant Drugs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Anticoagulant Drugs Market Size by Type
9.1.1 Asia Anticoagulant Drugs Sales by Type (2019-2030)
9.1.2 Asia Anticoagulant Drugs Revenue by Type (2019-2030)
9.2 Asia Anticoagulant Drugs Market Size by Application
9.2.1 Asia Anticoagulant Drugs Sales by Application (2019-2030)
9.2.2 Asia Anticoagulant Drugs Revenue by Application (2019-2030)
9.3 Asia Anticoagulant Drugs Sales by Region
9.3.1 Asia Anticoagulant Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Anticoagulant Drugs Revenue by Region (2019-2030)
9.3.3 Asia Anticoagulant Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anticoagulant Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Anticoagulant Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Anticoagulant Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Anticoagulant Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Anticoagulant Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Anticoagulant Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Overview
11.1.3 Bristol-Myers Squibb Anticoagulant Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bristol-Myers Squibb Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Myers Squibb Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Anticoagulant Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bayer Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Anticoagulant Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Pfizer Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Anticoagulant Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Johnson & Johnson Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Anticoagulant Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sanofi Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Anticoagulant Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Boehringer Ingelheim Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Information
11.7.2 Daiichi Sankyo Overview
11.7.3 Daiichi Sankyo Anticoagulant Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Daiichi Sankyo Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Daiichi Sankyo Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anticoagulant Drugs Industry Chain Analysis
12.2 Anticoagulant Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anticoagulant Drugs Production Mode & Process
12.4 Anticoagulant Drugs Sales and Marketing
12.4.1 Anticoagulant Drugs Sales Channels
12.4.2 Anticoagulant Drugs Distributors
12.5 Anticoagulant Drugs Customers
13 Market Dynamics
13.1 Anticoagulant Drugs Industry Trends
13.2 Anticoagulant Drugs Market Drivers
13.3 Anticoagulant Drugs Market Challenges
13.4 Anticoagulant Drugs Market Restraints
14 Key Findings in The Global Anticoagulant Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Bayer
Johnson & Johnson
Daiichi Sankyo
Pfizer Inc
Sanofi
Boehringer Ingelheim
List of Tables
    Table 1. Global Anticoagulant Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of NOACs
    Table 3. Major Manufacturers of Heparin
    Table 4. Major Manufacturers of Warfarin
    Table 5. Major Manufacturers of Others
    Table 6. Global Anticoagulant Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Anticoagulant Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Anticoagulant Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Anticoagulant Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Anticoagulant Drugs Revenue Market Share by Region (2019-2024)
    Table 11. Global Anticoagulant Drugs Revenue Market Share by Region (2025-2030)
    Table 12. Global Anticoagulant Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Anticoagulant Drugs Sales by Region (2019-2024) & (K Units)
    Table 14. Global Anticoagulant Drugs Sales by Region (2025-2030) & (K Units)
    Table 15. Global Anticoagulant Drugs Sales Market Share by Region (2019-2024)
    Table 16. Global Anticoagulant Drugs Sales Market Share by Region (2025-2030)
    Table 17. Global Anticoagulant Drugs Sales by Manufacturers (2019-2024) & (K Units)
    Table 18. Global Anticoagulant Drugs Sales Share by Manufacturers (2019-2024)
    Table 19. Global Anticoagulant Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Anticoagulant Drugs Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Anticoagulant Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Anticoagulant Drugs Price by Manufacturers 2019-2024 (USD/Unit)
    Table 23. Global Anticoagulant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Anticoagulant Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Drugs as of 2023)
    Table 25. Global Key Manufacturers of Anticoagulant Drugs, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Anticoagulant Drugs, Product Offered and Application
    Table 27. Global Key Manufacturers of Anticoagulant Drugs, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Anticoagulant Drugs Sales by Type (2019-2024) & (K Units)
    Table 30. Global Anticoagulant Drugs Sales by Type (2025-2030) & (K Units)
    Table 31. Global Anticoagulant Drugs Sales Share by Type (2019-2024)
    Table 32. Global Anticoagulant Drugs Sales Share by Type (2025-2030)
    Table 33. Global Anticoagulant Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Anticoagulant Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Anticoagulant Drugs Revenue Share by Type (2019-2024)
    Table 36. Global Anticoagulant Drugs Revenue Share by Type (2025-2030)
    Table 37. Anticoagulant Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 38. Global Anticoagulant Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 39. Global Anticoagulant Drugs Sales by Application (2019-2024) & (K Units)
    Table 40. Global Anticoagulant Drugs Sales by Application (2025-2030) & (K Units)
    Table 41. Global Anticoagulant Drugs Sales Share by Application (2019-2024)
    Table 42. Global Anticoagulant Drugs Sales Share by Application (2025-2030)
    Table 43. Global Anticoagulant Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Anticoagulant Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Anticoagulant Drugs Revenue Share by Application (2019-2024)
    Table 46. Global Anticoagulant Drugs Revenue Share by Application (2025-2030)
    Table 47. Anticoagulant Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 48. Global Anticoagulant Drugs Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 49. US & Canada Anticoagulant Drugs Sales by Type (2019-2024) & (K Units)
    Table 50. US & Canada Anticoagulant Drugs Sales by Type (2025-2030) & (K Units)
    Table 51. US & Canada Anticoagulant Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Anticoagulant Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Anticoagulant Drugs Sales by Application (2019-2024) & (K Units)
    Table 54. US & Canada Anticoagulant Drugs Sales by Application (2025-2030) & (K Units)
    Table 55. US & Canada Anticoagulant Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Anticoagulant Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Anticoagulant Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Anticoagulant Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Anticoagulant Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Anticoagulant Drugs Sales by Country (2019-2024) & (K Units)
    Table 61. US & Canada Anticoagulant Drugs Sales by Country (2025-2030) & (K Units)
    Table 62. Europe Anticoagulant Drugs Sales by Type (2019-2024) & (K Units)
    Table 63. Europe Anticoagulant Drugs Sales by Type (2025-2030) & (K Units)
    Table 64. Europe Anticoagulant Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Anticoagulant Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Anticoagulant Drugs Sales by Application (2019-2024) & (K Units)
    Table 67. Europe Anticoagulant Drugs Sales by Application (2025-2030) & (K Units)
    Table 68. Europe Anticoagulant Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Anticoagulant Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Anticoagulant Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Anticoagulant Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Anticoagulant Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Anticoagulant Drugs Sales by Country (2019-2024) & (K Units)
    Table 74. Europe Anticoagulant Drugs Sales by Country (2025-2030) & (K Units)
    Table 75. China Anticoagulant Drugs Sales by Type (2019-2024) & (K Units)
    Table 76. China Anticoagulant Drugs Sales by Type (2025-2030) & (K Units)
    Table 77. China Anticoagulant Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Anticoagulant Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Anticoagulant Drugs Sales by Application (2019-2024) & (K Units)
    Table 80. China Anticoagulant Drugs Sales by Application (2025-2030) & (K Units)
    Table 81. China Anticoagulant Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Anticoagulant Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Anticoagulant Drugs Sales by Type (2019-2024) & (K Units)
    Table 84. Asia Anticoagulant Drugs Sales by Type (2025-2030) & (K Units)
    Table 85. Asia Anticoagulant Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Anticoagulant Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Anticoagulant Drugs Sales by Application (2019-2024) & (K Units)
    Table 88. Asia Anticoagulant Drugs Sales by Application (2025-2030) & (K Units)
    Table 89. Asia Anticoagulant Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Anticoagulant Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Anticoagulant Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Anticoagulant Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Anticoagulant Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Anticoagulant Drugs Sales by Region (2019-2024) & (K Units)
    Table 95. Asia Anticoagulant Drugs Sales by Region (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Anticoagulant Drugs Sales by Type (2019-2024) & (K Units)
    Table 97. Middle East, Africa and Latin America Anticoagulant Drugs Sales by Type (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Anticoagulant Drugs Sales by Application (2019-2024) & (K Units)
    Table 101. Middle East, Africa and Latin America Anticoagulant Drugs Sales by Application (2025-2030) & (K Units)
    Table 102. Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Anticoagulant Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Anticoagulant Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Anticoagulant Drugs Sales by Country (2019-2024) & (K Units)
    Table 108. Middle East, Africa and Latin America Anticoagulant Drugs Sales by Country (2025-2030) & (K Units)
    Table 109. Bristol-Myers Squibb Company Information
    Table 110. Bristol-Myers Squibb Description and Major Businesses
    Table 111. Bristol-Myers Squibb Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 112. Bristol-Myers Squibb Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Bristol-Myers Squibb Recent Developments
    Table 114. Bayer Company Information
    Table 115. Bayer Description and Major Businesses
    Table 116. Bayer Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 117. Bayer Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Bayer Recent Developments
    Table 119. Pfizer Company Information
    Table 120. Pfizer Description and Major Businesses
    Table 121. Pfizer Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 122. Pfizer Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Pfizer Recent Developments
    Table 124. Johnson & Johnson Company Information
    Table 125. Johnson & Johnson Description and Major Businesses
    Table 126. Johnson & Johnson Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 127. Johnson & Johnson Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Johnson & Johnson Recent Developments
    Table 129. Sanofi Company Information
    Table 130. Sanofi Description and Major Businesses
    Table 131. Sanofi Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 132. Sanofi Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Sanofi Recent Developments
    Table 134. Boehringer Ingelheim Company Information
    Table 135. Boehringer Ingelheim Description and Major Businesses
    Table 136. Boehringer Ingelheim Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 137. Boehringer Ingelheim Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Boehringer Ingelheim Recent Developments
    Table 139. Daiichi Sankyo Company Information
    Table 140. Daiichi Sankyo Description and Major Businesses
    Table 141. Daiichi Sankyo Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 142. Daiichi Sankyo Anticoagulant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Daiichi Sankyo Recent Developments
    Table 144. Key Raw Materials Lists
    Table 145. Raw Materials Key Suppliers Lists
    Table 146. Anticoagulant Drugs Distributors List
    Table 147. Anticoagulant Drugs Customers List
    Table 148. Anticoagulant Drugs Market Trends
    Table 149. Anticoagulant Drugs Market Drivers
    Table 150. Anticoagulant Drugs Market Challenges
    Table 151. Anticoagulant Drugs Market Restraints
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anticoagulant Drugs Product Picture
    Figure 2. Global Anticoagulant Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anticoagulant Drugs Market Share by Type in 2023 & 2030
    Figure 4. NOACs Product Picture
    Figure 5. Heparin Product Picture
    Figure 6. Warfarin Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Anticoagulant Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Anticoagulant Drugs Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Pharmacy
    Figure 12. Others
    Figure 13. Anticoagulant Drugs Report Years Considered
    Figure 14. Global Anticoagulant Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Anticoagulant Drugs Revenue 2019-2030 (US$ Million)
    Figure 16. Global Anticoagulant Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Anticoagulant Drugs Revenue Market Share by Region (2019-2030)
    Figure 18. Global Anticoagulant Drugs Sales 2019-2030 ((K Units)
    Figure 19. Global Anticoagulant Drugs Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Anticoagulant Drugs Sales YoY (2019-2030) & (K Units)
    Figure 21. US & Canada Anticoagulant Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Anticoagulant Drugs Sales YoY (2019-2030) & (K Units)
    Figure 23. Europe Anticoagulant Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Anticoagulant Drugs Sales YoY (2019-2030) & (K Units)
    Figure 25. China Anticoagulant Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Anticoagulant Drugs Sales YoY (2019-2030) & (K Units)
    Figure 27. Asia (excluding China) Anticoagulant Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Anticoagulant Drugs Sales YoY (2019-2030) & (K Units)
    Figure 29. Middle East, Africa and Latin America Anticoagulant Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Anticoagulant Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Anticoagulant Drugs in the World: Market Share by Anticoagulant Drugs Revenue in 2023
    Figure 32. Global Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Anticoagulant Drugs Sales Market Share by Type (2019-2030)
    Figure 34. Global Anticoagulant Drugs Revenue Market Share by Type (2019-2030)
    Figure 35. Global Anticoagulant Drugs Sales Market Share by Application (2019-2030)
    Figure 36. Global Anticoagulant Drugs Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Anticoagulant Drugs Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Anticoagulant Drugs Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Anticoagulant Drugs Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Anticoagulant Drugs Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Anticoagulant Drugs Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Anticoagulant Drugs Sales Share by Country (2019-2030)
    Figure 43. U.S. Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Anticoagulant Drugs Sales Market Share by Type (2019-2030)
    Figure 46. Europe Anticoagulant Drugs Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Anticoagulant Drugs Sales Market Share by Application (2019-2030)
    Figure 48. Europe Anticoagulant Drugs Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Anticoagulant Drugs Revenue Share by Country (2019-2030)
    Figure 50. Europe Anticoagulant Drugs Sales Share by Country (2019-2030)
    Figure 51. Germany Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 52. France Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 56. China Anticoagulant Drugs Sales Market Share by Type (2019-2030)
    Figure 57. China Anticoagulant Drugs Revenue Market Share by Type (2019-2030)
    Figure 58. China Anticoagulant Drugs Sales Market Share by Application (2019-2030)
    Figure 59. China Anticoagulant Drugs Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Anticoagulant Drugs Sales Market Share by Type (2019-2030)
    Figure 61. Asia Anticoagulant Drugs Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Anticoagulant Drugs Sales Market Share by Application (2019-2030)
    Figure 63. Asia Anticoagulant Drugs Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Anticoagulant Drugs Revenue Share by Region (2019-2030)
    Figure 65. Asia Anticoagulant Drugs Sales Share by Region (2019-2030)
    Figure 66. Japan Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 70. India Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Anticoagulant Drugs Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Anticoagulant Drugs Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Anticoagulant Drugs Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Anticoagulant Drugs Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Anticoagulant Drugs Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Anticoagulant Drugs Sales Share by Country (2019-2030)
    Figure 77. Brazil Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Anticoagulant Drugs Revenue (2019-2030) & (US$ Million)
    Figure 82. Anticoagulant Drugs Value Chain
    Figure 83. Anticoagulant Drugs Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions